Daily as of 3 Nov 16:00 ET
- Price
- between the two $36.04 vs 50 $36.63 / 200 $31.63
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 23 Jul 2025 · projected 15 bars out · tested 1 bar
ROIV | Roivant SciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$36.04
+$0.15 (+0.42%)
Roivant Sciences (ROIV) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat above the 200 on the daily since Jul 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits above the 50 and the 200; on the daily it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $36.91 vs 50 $29.81 / 200 $15.74
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 13:30 ET
- Price
- above both $36.47 vs 50 $35.59 / 200 $35.58
- Projection
- 💀Death cross projected in 1 bar
- Test
- No active test
- Last cross
- 🟨Golden cross 16 May 2025 · projected 27 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 23 Jul 2025 | 🟨Golden flat | daily | 15 bars out | 1 bar cross test |
| 16 May 2025 | 🟨Golden | 4-hour | 27 bars out | — |
| 18 Feb 2025 | 💀Death | daily | 28 bars out | Not tested |
| 13 Jan 2025 | 💀Death | 4-hour | 25 bars out | — |
| 23 Aug 2024 | 🟨Golden | 4-hour | 6 bars out | — |
About ROIV
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$219M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandlarge